AAP
38
-4
GM
55
6
PX
50
-3
SYK
46
-4
LEN
23
-11
KMI
42
2
ADP
66
-2
EQIX
65
-3
NVDA
61
-3
HAL
43
2
ZION
65
-2
BDX
33
-2
SLG
53
-3
AMGN
26
-2
STT
67
-4
CSX
34
-2
AMAT
64
-2
CMG
47
4
ROP
50
-4
JNJ
50
-3
AAP
38
-4
GM
55
6
PX
50
-3
SYK
46
-4
LEN
23
-11
KMI
42
2
ADP
66
-2
EQIX
65
-3
NVDA
61
-3
HAL
43
2
ZION
65
-2
BDX
33
-2
SLG
53
-3
AMGN
26
-2
STT
67
-4
CSX
34
-2
AMAT
64
-2
CMG
47
4
ROP
50
-4
JNJ
50
-3
Financhill
Back

Sabra Health Care REIT Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
84

SBRA
Sabra Health Care REIT

Last Price:
$18.37
Seasonality Move:
1.88%
Buy
66

HALO
Halozyme Therapeutics

Last Price:
$54.30
Seasonality Move:
1.46%
Buy
84
Sabra Health Care REIT (SBRA) is a Buy

Is Sabra Health Care REIT a Buy, Sell or Hold?

  • The current Sabra Health Care REIT [SBRA] share price is $18.25. The Score for SBRA is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • SBRA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
66
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $53.85. The Score for HALO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SBRA Stock Price Chart

What is Sabra Health Care REIT's stock price today?

  • The Sabra Health Care REIT share price today is $18.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SBRA is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $53.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SBRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 62.28 Buy
Chaikin Money Flow: 415901 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.42 - 18.02) Buy
Bollinger Bands (100): (16.7 - 17.78) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.16 Sell
Relative Strength Index (14 RSI): 44.3 Sell
Chaikin Money Flow: -1230050 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.07 - 61.19) Sell
Bollinger Bands (100): (54.45 - 62.43) Sell

SBRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.79 Buy
20-day SMA: 17.66 Buy
50-day SMA: 17.61 Buy
200-day SMA: 17.62 Buy
8-day EMA: 17.86 Buy
20-day EMA: 17.73 Buy
50-day EMA: 17.59 Buy
200-day EMA: 17.12 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.08 Sell
20-day SMA: 53.5 Buy
50-day SMA: 57.81 Sell
200-day SMA: 56.21 Sell
8-day EMA: 54.1 Sell
20-day EMA: 54.95 Sell
50-day EMA: 56.76 Sell
200-day EMA: 55.21 Sell

Sabra Health Care REIT Earnings Growth & SBRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.07 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

Sabra Health Care REIT Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):